Cyclo (RGDyC)
This cyclic RGD pentapeptide is an anti-angiogenic agent used in research on cancer and ocular diseases. It is commonly employed in both in vitro cell adhesion assays and in vivo models to study integrin-mediated neovascularization, often formulated in liposomal systems for targeted delivery studies.
Product Specifications
Molecular Weight
594.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog